L1 protein, human papillomavirus type 11 vaccine 0.08 mg/ML / L1 protein, human papillomavirus type 16 vaccine 0.12 mg/ML / L1 protein, human papillomavirus type 18 vaccine 0.08 mg/ML / L1 protein, human papillomavirus type 31 vaccine 0.04 mg/ML / L1 protein, human papillomavirus type 33 vaccine 0.04 mg/ML / L1 protein, human papillomavirus type 45 vaccine 0.04 mg/ML / L1 protein, human papillomavirus type 52 vaccine 0.04 mg/ML / L1 protein, human papillomavirus type 58 vaccine 0.04 mg/ML / L1 protein, human papillomavirus type 6 vaccine 0.06 mg/ML [Gardasil 9]
RxNorm 1597096
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1597096 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: L1 protein, human papillomavirus type 11 vaccine 0.08 mg/ML / L1 protein, human papillomavirus type 16 vaccine 0.12 mg/ML / L1 protein, human papillomavirus type 18 vaccine 0.08 mg/ML / L1 protein, human papillomavirus type 31 vaccine 0.04 mg/ML / L1 protein, human papillomavirus type 33 vaccine 0.04 mg/ML / L1 protein, human papillomavirus type 45 vaccine 0.04 mg/ML / L1 protein, human papillomavirus type 52 vaccine 0.04 mg/ML / L1 protein, human papillomavirus type 58 vaccine 0.04 mg/ML / L1 protein, human papillomavirus type 6 vaccine 0.06 mg/ML [Gardasil 9].
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
Semantic Branded Drug Component (SBDC):
L1 protein, human papillomavirus type 11 vaccine 0.08 mg/ML / L1 protein, human papillomavirus type 16 vaccine 0.12 mg/ML / L1 protein, human papillomavirus type 18 vaccine 0.08 mg/ML / L1 protein, human papillomavirus type 31 vaccine 0.04 mg/ML / L1 protein, human papillomavirus type 33 vaccine 0.04 mg/ML / L1 protein, human papillomavirus type 45 vaccine 0.04 mg/ML / L1 protein, human papillomavirus type 52 vaccine 0.04 mg/ML / L1 protein, human papillomavirus type 58 vaccine 0.04 mg/ML / L1 protein, human papillomavirus type 6 vaccine 0.06 mg/ML [Gardasil 9]
(Atom ID: 12311038)
Patient Education
Human Papillomavirus (HPV) Vaccine
Why get vaccinated? HPV vaccine prevents infection with human papillomavirus (HPV) types that are associated with cause many cancers, including the following: cervical cancer in females vaginal and vulvar cancers in females anal cancer in females and males throat cancer in females and males penile cancer in males In addition, HPV vaccine prevents infection with HPV types that cause genital warts in both females and males. In the United States, about 12,000 women get cervical cancer every year, and about 4,000 women die from it. HPV vaccine can prevent most of these cases of cervical cancer. Vaccination is not a substitute for cervical cancer screening. This vaccine does not protect against all HPV types that can cause cervical cancer. Women should still get regular Pap tests. HPV infection usually comes from sexual contact, and most people will become infected at some point in their life. About 14 million Americans, including teens, get infected every year. Most infections will go away on their own and not cause serious problems. But thousands of women and men get cancer and other diseases from HPV.
[Learn More]
* Please review the disclaimer below.
